221 related articles for article (PubMed ID: 26105140)
1. Effects of Escitalopram Administration on Face Processing in Intermittent Explosive Disorder: An fMRI Study.
Cremers H; Lee R; Keedy S; Phan KL; Coccaro E
Neuropsychopharmacology; 2016 Jan; 41(2):590-7. PubMed ID: 26105140
[TBL] [Abstract][Full Text] [Related]
2. Amygdala hyperactivation to angry faces in intermittent explosive disorder.
McCloskey MS; Phan KL; Angstadt M; Fettich KC; Keedy S; Coccaro EF
J Psychiatr Res; 2016 Aug; 79():34-41. PubMed ID: 27145325
[TBL] [Abstract][Full Text] [Related]
3. Area-specific modulation of neural activation comparing escitalopram and citalopram revealed by pharmaco-fMRI: a randomized cross-over study.
Windischberger C; Lanzenberger R; Holik A; Spindelegger C; Stein P; Moser U; Gerstl F; Fink M; Moser E; Kasper S
Neuroimage; 2010 Jan; 49(2):1161-70. PubMed ID: 19833214
[TBL] [Abstract][Full Text] [Related]
4. Functional brain responses to emotional faces after three to five weeks of intake of escitalopram in healthy individuals: a double-blind, placebo-controlled randomised study.
Armand S; Langley C; Johansen A; Ozenne B; Overgaard-Hansen O; Larsen K; Jensen PS; Knudsen GM; Sahakian BJ; Stenbæk DS; Fisher PM
Sci Rep; 2024 Feb; 14(1):3149. PubMed ID: 38326352
[TBL] [Abstract][Full Text] [Related]
5. Escitalopram effects on insula and amygdala BOLD activation during emotional processing.
Arce E; Simmons AN; Lovero KL; Stein MB; Paulus MP
Psychopharmacology (Berl); 2008 Mar; 196(4):661-72. PubMed ID: 18058090
[TBL] [Abstract][Full Text] [Related]
6. Combining escitalopram and cognitive-behavioural therapy for social anxiety disorder: randomised controlled fMRI trial.
Gingnell M; Frick A; Engman J; Alaie I; Björkstrand J; Faria V; Carlbring P; Andersson G; Reis M; Larsson EM; Wahlstedt K; Fredrikson M; Furmark T
Br J Psychiatry; 2016 Sep; 209(3):229-35. PubMed ID: 27340112
[TBL] [Abstract][Full Text] [Related]
7. Effect of Citalopram on Emotion Processing in Humans: A Combined 5-HT
Selvaraj S; Walker C; Arnone D; Cao B; Faulkner P; Cowen PJ; Roiser JP; Howes O
Neuropsychopharmacology; 2018 Feb; 43(3):655-664. PubMed ID: 28776580
[TBL] [Abstract][Full Text] [Related]
8. A double-blind, randomized, placebo-controlled trial of fluoxetine in patients with intermittent explosive disorder.
Coccaro EF; Lee RJ; Kavoussi RJ
J Clin Psychiatry; 2009 Apr; 70(5):653-62. PubMed ID: 19389333
[TBL] [Abstract][Full Text] [Related]
9. Multicenter, randomized, placebo-controlled, double-blind clinical trial of escitalopram on the progression-delaying effects in Alzheimer's disease.
Choe YM; Kim KW; Jhoo JH; Ryu SH; Seo EH; Sohn BK; Byun MS; Bak JH; Lee JM; Yun HJ; Han MI; Woo JI; Lee DY
Int J Geriatr Psychiatry; 2016 Jul; 31(7):731-9. PubMed ID: 26553313
[TBL] [Abstract][Full Text] [Related]
10. The effect of selective serotonin reuptake inhibitors in healthy first-degree relatives of patients with major depressive disorder - an experimental medicine blinded controlled trial.
Knorr UB
Dan Med J; 2012 Apr; 59(4):B4426. PubMed ID: 22459724
[TBL] [Abstract][Full Text] [Related]
11. Early changes in emotional processing as a marker of clinical response to SSRI treatment in depression.
Godlewska BR; Browning M; Norbury R; Cowen PJ; Harmer CJ
Transl Psychiatry; 2016 Nov; 6(11):e957. PubMed ID: 27874847
[TBL] [Abstract][Full Text] [Related]
12. Escitalopram treatment of kleptomania: an open-label trial followed by double-blind discontinuation.
Koran LM; Aboujaoude EN; Gamel NN
J Clin Psychiatry; 2007 Mar; 68(3):422-7. PubMed ID: 17388713
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
Pelissolo A
Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
[TBL] [Abstract][Full Text] [Related]
14. Differential fMRI BOLD responses in amygdala in intermittent explosive disorder as a function of past Alcohol Use Disorder.
Coccaro EF; Keedy SK; Gorka SM; King AC; Fanning JR; Lee RJ; Phan KL
Psychiatry Res Neuroimaging; 2016 Nov; 257():5-10. PubMed ID: 27693977
[TBL] [Abstract][Full Text] [Related]
15. The impact of 5-HTTLPR on acute serotonin transporter blockade by escitalopram on emotion processing: preliminary findings from a randomised, crossover fMRI study.
Outhred T; Das P; Dobson-Stone C; Felmingham KL; Bryant RA; Nathan PJ; Malhi GS; Kemp AH
Aust N Z J Psychiatry; 2014 Dec; 48(12):1115-25. PubMed ID: 24810870
[TBL] [Abstract][Full Text] [Related]
16. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients.
Burke WJ; Gergel I; Bose A
J Clin Psychiatry; 2002 Apr; 63(4):331-6. PubMed ID: 12000207
[TBL] [Abstract][Full Text] [Related]
17. Impact of acute administration of escitalopram on the processing of emotional and neutral images: a randomized crossover fMRI study of healthy women.
Outhred T; Das P; Felmingham KL; Bryant RA; Nathan PJ; Malhi GS; Kemp AH
J Psychiatry Neurosci; 2014 Jul; 39(4):267-75. PubMed ID: 24690370
[TBL] [Abstract][Full Text] [Related]
18. Do You Believe It? Verbal Suggestions Influence the Clinical and Neural Effects of Escitalopram in Social Anxiety Disorder: A Randomized Trial.
Faria V; Gingnell M; Hoppe JM; Hjorth O; Alaie I; Frick A; Hultberg S; Wahlstedt K; Engman J; Månsson KNT; Carlbring P; Andersson G; Reis M; Larsson EM; Fredrikson M; Furmark T
EBioMedicine; 2017 Oct; 24():179-188. PubMed ID: 29033138
[TBL] [Abstract][Full Text] [Related]
19. Acute neurofunctional effects of escitalopram during emotional processing in pediatric anxiety: a double-blind, placebo-controlled trial.
Lu L; Li H; Baumel WT; Mills JA; Cecil KM; Schroeder HK; Mossman SA; Huang X; Gong Q; Sweeney JA; Strawn JR
Neuropsychopharmacology; 2022 Apr; 47(5):1081-1087. PubMed ID: 34580419
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
Kennedy SH; Andersen HF; Lam RW
J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
